Sale!

CDKN1C Gene Beckwith-Wiedemann Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CDKN1C Gene Beckwith-Wiedemann Syndrome Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the CDKN1C gene, which are associated with Beckwith-Wiedemann Syndrome (BWS). Beckwith-Wiedemann Syndrome is a congenital overgrowth disorder that affects various parts of the body and increases the risk of developing certain types of tumors. This genetic test plays a crucial role in the early detection and management of BWS, enabling healthcare providers to implement appropriate surveillance and treatment strategies for affected individuals. The test is priced at 4400 AED and is conducted in the state-of-the-art facilities of DNA Labs UAE, ensuring high accuracy and reliability of results. Through this test, families can gain valuable insights into the genetic basis of BWS, facilitating informed decisions regarding healthcare and family planning.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CDKN1C Gene Beckwith-Wiedemann syndrome Genetic Test

Test Details

The CDKN1C gene is associated with Beckwith-Wiedemann syndrome (BWS), a rare genetic disorder characterized by overgrowth, abdominal wall defects, an increased risk of developing certain tumors, and other features.

NGS (Next-Generation Sequencing) is a type of genetic test that can be used to analyze the CDKN1C gene for mutations or variations. This test can help diagnose BWS and identify specific genetic changes that may be contributing to the disorder.

The NGS genetic test for CDKN1C gene mutations in BWS typically involves obtaining a sample of DNA, usually through a blood sample or cheek swab, and then sequencing the DNA to examine the specific sequence of the CDKN1C gene. This allows for the identification of any mutations or variations that may be present.

By identifying mutations or variations in the CDKN1C gene, healthcare professionals can confirm a diagnosis of BWS and provide appropriate medical management and genetic counseling for individuals and families affected by the disorder.

Test Name: CDKN1C Gene Beckwith-Wiedemann syndrome Genetic Test

Components:

  • Price: 4400.0 AED

Sample Condition:

  • Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery:

  • 3 to 4 Weeks

Method:

  • NGS Technology

Test Type:

  • Cancer

Doctor:

  • Oncologist

Test Department:

  • Genetics

Pre Test Information:

Clinical History of Patient who is going for CDKN1C Gene Beckwith-Wiedemann syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDKN1C Gene Beckwith-Wiedemann syndrome NGS Genetic DNA Test gene CDKN1C

Test Name CDKN1C Gene Beckwith-Wiedemann syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cancer
Doctor Oncologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CDKN1C Gene Beckwith-Wiedemann syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDKN1C Gene Beckwith-Wiedemann syndrome NGS Genetic DNA Test gene CDKN1C
Test Details

The CDKN1C gene is associated with Beckwith-Wiedemann syndrome (BWS), a rare genetic disorder characterized by overgrowth, abdominal wall defects, an increased risk of developing certain tumors, and other features.

NGS (Next-Generation Sequencing) is a type of genetic test that can be used to analyze the CDKN1C gene for mutations or variations. This test can help diagnose BWS and identify specific genetic changes that may be contributing to the disorder.

The NGS genetic test for CDKN1C gene mutations in BWS typically involves obtaining a sample of DNA, usually through a blood sample or cheek swab, and then sequencing the DNA to examine the specific sequence of the CDKN1C gene. This allows for the identification of any mutations or variations that may be present.

By identifying mutations or variations in the CDKN1C gene, healthcare professionals can confirm a diagnosis of BWS and provide appropriate medical management and genetic counseling for individuals and families affected by the disorder.